ABUS
NASDAQStockArbutus Biopharma Corporation
$4.25-0.07 (-1.50%)
52-Week Range
$2.88
$4.95
Key Stats
Market Cap
818.3M
P/E Ratio
—
Dividend Yield
—
Beta
0.74
Volume
1.2M
Avg Volume
3.3M
Performance
1M
+7.73%
3M
-12.73%
6M
-4.64%
YTD
-9.43%
1Y
+30.91%
3Y
+42.57%
5Y
+14.29%
Price Chart
ETF Exposure
ABUS is held by 93 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 3.00% |
| GERM | ETFMG Treatments, Testing and Advancements ETF | 1.62% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.71% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.51% |
| IWC | iShares Micro-Cap ETF | 0.15% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.11% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.11% |
| CURE.AX | Global X - S&P Biotech ETF | 0.11% |
| XBI | State Street SPDR S&P Biotech ETF | 0.11% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.10% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.07% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.07% |
| IBB | iShares Biotechnology ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.05% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.05% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.04% |
| IWO | iShares Russell 2000 Growth ETF | 0.04% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.02% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.02% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.02% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| PWS | Pacer WealthShield ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | 0.01% |
Page 1 of 2Next
About ABUS ETF Exposure
Arbutus Biopharma Corporation (ABUS) is held by 93 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 818.3M, ABUS is a widely held institutional stock. The stock currently trades at $4.25. Investors can gain exposure to ABUS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABUS, sorted by portfolio weight.